Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer
The total morphine equivalents used were, however, not significantly different between arms.
American Head & Neck Society (AHNS)
ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer
These findings were, however, significant only in states that expanded Medicaid eligibility.
SLNBs Feasible After Wide Local Excisions in Melanoma of the Head and Neck
Sentinel nodes were accurately identified in all 30 patients who underwent WLE.
Acetaminophen May Decrease Opioid Use After Head and Neck Cancer Surgery
The number of PCA attempts did not differ between treatment arms.
Adjuvant Chemoradiotherapy Improves 5-Year OS in Salivary Squamous Cell Carcinoma
Approximately 50% and 30% of patients with late- and early-stage disease, respectively, undergo surgery without adjuvant therapy.
Adjuvant Radiation May Improve Survival in Head and Neck Cancer
The benefit of adjuvant radiotherapy in this setting was previously unestablished.
Celecoxib Reduces Opioid Use After Surgery in Head and Neck Cancer
The mean total opioid morphine equivalent use in the celecoxib arm was 31.8 mg vs 45 mg in the control arm.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AHNS 2018
Loading... 
Loading...